title: [Induction of labor by misoprostol, an analog of PGE1. A prospective study of 200 cases].
abstract: We carried out a prospective study of 200 pregnant women who required induction of labor at full term, at the Lalla Meryem maternity unit of the Ibn Rochd University Hospital, Casablanca, between January 1st 1996 and June 30th 1997. The aim of this study was to evaluate the efficacy, tolerance and acceptance of misoprostol (Cytotec) as a drug for inducing labor in unfavorable conditions (Bishop < 5). Misoprostol (a PGE1 analog) was administered to the women via the vagina, with a dose of 1/4 tb (50 mg) given every 6 hours, and a maximum of 3 doses (150 mg). If labor had not begun 18 h after the start of the protocol, misoprostol induction was considered to have failed. We found that misoprostol failed to induce labor in 5% of cases, Syntocinon was required in 40% of cases and the interval between misoprostol insertion and vaginal delivery was 13.3 + 11.1 h. The rate of delivery by cesarean section was 22% and the mean amount of misoprostol required was 1.3 doses (66 mg). The mean cost of labor induction was 0.6 FF, the frequency of uterine hyperstimulation was 3.5% and maternal, fetal and neonatal tolerance was good. Our results confirm that intravaginal misoprostol is very effective and well tolerated for the induction of labor in pregnant women at full term, in unfavorable obstetric conditions.
authors.affiliation: Lotissement El-Manar, Groupe O, n 3, Casablanca, Maroc.
authors.forename: T
authors.initials: T
authors.lastname: Chraibi
authors.forename: A
authors.initials: A
authors.lastname: Aboulfalah
authors.forename: W
authors.initials: W
authors.lastname: Bisbis
authors.forename: M
authors.initials: M
authors.lastname: Noun
authors.forename: N
authors.initials: N
authors.lastname: Matar
authors.forename: N
authors.initials: N
authors.lastname: Samouh
authors.forename: A
authors.initials: A
authors.lastname: Himmi
mesh_terms: D000282:Administration, Intravaginal; D000328:Adult; D001034:Apgar Score; D001724:Birth Weight; D002585:Cesarean Section; D005260:Female; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000175:diagnosis; D007751:Labor, Induced / Q000379:methods*; D008423:Maternal Age; D016595:Misoprostol / Q000008:administration & dosage*; D010120:Oxytocics; D011247:Pregnancy; D011248:Pregnancy Complications; D011446:Prospective Studies
chemical_list: D010120:Oxytocics; D016595:Misoprostol